Home Pilots Tasso receives FDA 510(k) for patch-like home blood collection device Pilots Tasso receives FDA 510(k) for patch-like home blood collection device By - September 14, 2022 36 0 Facebook Twitter Pinterest WhatsApp The company said the clearance will allow more pharma companies to use Tasso+ for decentralized clinical trials. RELATED ARTICLESMORE FROM AUTHOR Pilots Medtronic issues voluntary recall of MiniMed insulin pumps Pilots Hybrid primary care company Rezilient Health scores $10M Pilots Empathy Health Technologies raises $2.8M for Sober Sidekick app LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES LiveMetric receives FDA 510(k) for watch-like blood pressure monitor Pilots - July 7, 2022 0 Roundup: MSK DTx FlexifyMe scores $1M seed funding and more briefs Pilots - October 6, 2023 0 Mental health startup Grow Therapy scores $75M in Series B funding Pilots - September 30, 2022 0 Roundup: AI cardiac solutions startup Tricog scores $9M funding and more briefs Pilots - April 28, 2023 0 Workplace mental health company Unmind acquires Frankie Health Pilots - February 2, 2023 0 POPULAR CATEGORIESPilots2166Applications682Testing237Collaborations15GitHub3